We research innovative therapies to improve quality of life.
Introduction of Pipeline
Founded in 2002, Cellex Incorporated is a biotech company that develops technologies, instruments and assays for testing of human diseases and conditions, particularly for point-of-care (POC) professional healthcare settings. Based in Morrisville, NC, the company maintains both a GMP manufacturing site in Suzhou.Founded in 2002, Cellex Incorporated is a biotech company that develops technologies, instruments and assays for testing of human diseases and conditions, particularly for point-of-care (POC) professional healthcare settings. Based in Morrisville, NC, the company maintains both a GMP manufacturing site in Suzhou.
Nucleic acid molecule
- Gastroesophageal reflux disease drugs
- Diabetes drugs/Obesity drugs
- Fibrosis drugs
- Autoimmunity drugs
- (Targeted, Immuno-) Cancer drugs
Nucleic acid molecule
- Gastroesophageal reflux disease drugs
- Diabetes drugs/Obesity drugs
- Fibrosis drugs
- Autoimmunity drugs
Nucleic acid molecule
- Gastroesophageal reflux disease drugs
- Diabetes drugs/Obesity drugs
- Fibrosis drugs
- Autoimmunity drugs
- (Targeted, Immuno-) Cancer drugs Cancer drugs Cancer drugs
Persistently researching to achieve
a synergy of beauty and
technology in medical aesthetics.
Global Standard R&D Capabilities
With approvals for botulinum toxin injectables in over 70 countries worldwide, Hugel has demonstrated its R&D capabilities that meet global standards.
Open Innovation
The venture companies we supported haveattracted a total of 38 billion won in follow-upinvestments, been selected for national R&Dprojects, and named to the SLUSH 100, Europe'slargest startup conference.
Outstanding R&D Center
By the Ministry of Science and ICT, Hugel hasbeen selected as a "Certified Outstanding R&DCenter," proving its technological innovationcapabilities and value creation.
Open Innovation
Botulinum Toxin
Hyaluronic Acid filler
To maximize the effectiveness of hyaluronic acid fillers, we are developing fillers with various functionalities, aiming tooffer awide range of fillers tailored to customers' needs.
Botulinum Toxin
Innovation is more than invention – it's the relentless pursuit of better for patients
Founded in 2002, Cellex Incorporated is a biotech company that develops technologies, instruments and assays for testing of human diseases and conditions, particularly for point-of-care (POC) professional healthcare settings. Based in Morrisville, NC, the company maintains both a GMP manufacturing site in Suzhou.
Accelerating drug
development with AI
We’re harnessing technology to deliver better medicines to patients faster.
The tools powering tomorrow’s discoveries
Founded in 2002, Cellex Incorporated is a biotech company that develops technologies, instruments and assays for testing of human diseases and conditions, particularly for point-of-care (POC) professional healthcare settings. Based in Morrisville, NC, the company maintains both a GMP manufacturing site in Suzhou.
Oncology | 2026.06.12 | 2026.05.19
Three ways Al is changing drugdiscovery at AbbVie
If you have a question or need more information about us, find out who you shouldcontact here.
Read More
Oncology | 2026.06.12 | 2026.05.19
Three ways Al is changing drugdiscovery at AbbVie
If you have a question or need more information about us, find out who you shouldcontact here.
Read More
Oncology | 2026.05.18
Three ways AI is changing drug discovery at AbbVie
If you have a question or need more information about us, find out who you should contact here.
Read More
Our therapeutic areas
And we’re not
slowing down
From the discovery to the delivery of medicine, we are doubling down on bold approaches to scientific innovation.
2002
Founded in 2002, Cellex Incorporated is a biotech company that develops technologies
~ 6
years
Reduced first human dose to medicine launch from ~11years to ~6years.
23
Medicines launched globally in a single decade, including game-changing therapies for diabetes, obesity and Alzheimer’s disease.